vrnof-20240229
0001848416TRUE00018484162024-02-292024-02-29


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
(Amendment No. 2)

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 29, 2024
VERANO HOLDINGS CORP.
(Exact Name of Registrant as Specified in its Charter)
British Columbia000-5634298-1583243
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
224 W Hill Street, Suite 400,
Chicago, Illinois 60610
(Address of Principal Executive Offices) (Zip Code)
(312) 265-0730
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
N/AN/AN/A
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Explanatory Note

On February 29, 2024, Verano Holdings Corp. (the “Company”) filed a Current Report on Form 8-K furnishing under Items 2.02 and 9.01 the Company’s press release announcing its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023 (as amended, the “Original Filing”). The full text of the press release (the “Earnings Release”) was included as Exhibit 99.1 to the Original Filing.

This Amendment No. 2 (this “Amendment”) to the Original Filing is being filed to reissue the Earnings Release to modify certain financial statement information in the Earnings Release related to an adjustment related to an impairment of property, plant and equipment. This adjustment was identified by the Company’s management after the date of the Original Filing and as part of the Company’s customary procedures to finalize its financial statements for inclusion in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Form 10-K”), including the completion of the independent audit of such financial statements.

Item 2.02 Results of Operations and Financial Condition

This Amendment is being filed to make certain modifications to information included in the Earnings Release, including modifications made in connection with the completion of the independent audit of the Company's financial statements. The Earnings Release attached hereto as Exhibit 99.1 provides an updated presentation of the Company’s “Highlights from Consolidated Statements of Operations,” “Highlights from Consolidated Balance Sheets,” “Reconciliation of Net Loss to EBITDA (Non-U.S. GAAP)” and “Reconciliation of Net Loss to EBIT (Non-U.S. GAAP and Adjusted EBITDA (Non-U.S. GAAP)”.

The Company completed its property, plant and equipment fair value assessment on March 13, 2024 and management determined that U.S. Generally Accepted Accounting Principles required a “property, plant and equipment (“Fixed Asset”), impairment” charge on the Company’s “Consolidated Statements of Operations” for the quarter and fiscal year ended December 31, 2023, resulting in a $4,629 thousand increase to the fourth quarter and annual net loss. The Company also reduced the balances of “Property, Plant and Equipment, net” on the “Consolidated Balance Sheet” as of December 31, 2023 by $8,573 thousand. The property, plant and equipment impairment does not have an impact on the Company’s compliance with covenants under any outstanding credit agreements. The impairment charge did not result in any current cash expenditures.

The Company evaluates the carrying value of long-lived assets at the end of each reporting period whenever there is any indication that a long-lived asset is impaired. The Company estimated the recoverable amount of its Massachusetts cultivation facility, noting that such asset could be impaired given its carrying amount exceeded its recoverable amount. The Company utilized a third party appraiser to estimate the fair value of such fixed asset. The Company’s assessment concluded that such fixed asset was impaired.

As a result of these changes, conforming modifications were made to the body of the Earnings Release. The Earnings Release has been reissued to reflect such new information, and a copy of the Earnings Release for the quarter and year ended December 31, 2023 is attached to this Amendment as Exhibit 99.1. Except as described herein and in Exhibit 99.1, this Amendment does not modify or update any other disclosure contained in or furnished with the Original Filing, and this Amendment should be read in conjunction therewith.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits:

104         Cover Page Interactive Data File (embedded within the inline XRBL document)





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Dated: March 15, 2024

By:/s/ Brett Summerer
Name:Brett Summerer
Title:Chief Financial Officer

Document

https://cdn.kscope.io/2eb7d79e418fecf02d73330b2c06056e-capture1a.jpg
Verano Announces Revised Fourth Quarter and Full Year 2023 Financial Results

Record Revenue of $938 Million
Increased 2023 Net Cash Provided by Operating Activities by 16% to $110 Million
Generated $73 million in Free Cash Flow1 for 2023, Meeting Guidance

CHICAGO, March 15, 2024 (GLOBE NEWSWIRE) – Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced revised financial results for the fourth quarter and full year ended December 31, 2023, which were prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

Subsequent to the filing of the original press release on February 29, 2024, the Company obtained new information related to the fair value of its Massachusetts cultivation facility and recorded a corresponding $9 million fixed asset impairment. As a result, the Property, Plant and Equipment, net balance has been reduced by $9 million and net income has been reduced by $5 million as a result of the impairment, net of tax effects. As a result of these changes, conforming modifications were also made to certain ratios.


Fourth Quarter and Full Year 2023 Financial Highlights
For the Three Months Ended,For the Year Ended,
($ in thousands)December 31, 2023September 30, 2023December 31, 2022December 31, 2023December 31, 2022
Revenues, net of Discounts$237,189 $240,088 $225,927 $938,452 $879,412 
Gross Profit117,610 133,220 103,336 475,206 423,062 
Income (Loss) from Operations(19,716)40,288 (206,977)84,784 (161,131)
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries(77,208)(17,842)(216,110)(117,348)(269,164)
Adjusted EBITDA2
73,376 89,349 78,713 304,871 323,567 

Fourth Quarter 2023 Financial Highlights
Revenue of $237 million, an increase of 5% year-over-year, and decrease of 1% versus the prior quarter.
Gross profit of $118 million or 50% of revenue.
SG&A expense of $86 million or 36% of revenue.
Net loss of $(77) million or (33)% of revenue.
Adjusted EBITDA2 of $73 million or 31% of revenue.
Net cash provided by operating activities of $32 million.
Capital expenditures of $10 million.
Free cash flow1 of $23 million.

Full Year 2023 Financial Highlights
Revenue of $938 million, an increase of 7% year-over-year.
Gross profit of $475 million or 51% of revenue.
SG&A expense of $332 million or 35% of revenue.
Net loss of $(117) million or (13)% of revenue.
Adjusted EBITDA2 of $305 million or 32% of revenue.
Net cash provided by operating activities of $110 million.
Capital expenditures of $36 million.
Free cash flow1 of $73 million.

1


Management Commentary
“I'm incredibly proud of our performance in 2023, highlighted by key wins across all aspects of the business," said George Archos, Verano Founder and Chief Executive Officer. "As excitement and anticipation builds in the industry, 2024 has the potential to be a game-changing year, and Verano is well positioned to continue capitalizing on growth opportunities both in the current regulatory environment and from any state or federal reform. While we’ve never been dependent on legislation to drive sustained growth, with adult use imminent in Ohio, on the horizon in Florida and Pennsylvania, and the growing anticipation of a federal rescheduling decision, there is limitless potential for Verano. I’m thankful for all that our team accomplished in 2023, and believe the sky is the limit for what we can achieve in 2024 and beyond.”


Fourth Quarter 2023 Financial Overview
Revenue for the fourth quarter 2023 was $237 million, up 5% from $226 million for the fourth quarter 2022, and down 1% from $240 million for the third quarter 2023. The increase in revenue for the fourth quarter 2023 compared to the fourth quarter 2022 was driven primarily by strength from wholesale adult use sales in New Jersey, in addition to growth in Maryland and Florida retail.

Gross profit for the fourth quarter 2023 was $118 million or 50% of revenue, up from $103 million or 46% of revenue for the fourth quarter 2022, and down from $133 million or 55% of revenue for the third quarter 2023. The increase in gross profit for the fourth quarter 2023 compared to the fourth quarter 2022 was driven primarily by increased vertical mix and revenue growth.

SG&A expense for the fourth quarter 2023 was $86 million or 36% of revenue, up from $81 million or 36% of revenue for the fourth quarter 2022, and flat with $86 million or 36% of revenue for the third quarter 2023.

Net loss for the fourth quarter 2023 was $(77) million, or (33)% of revenue, versus a loss of $(216) million in the fourth quarter 2022, and $(18) million for the third quarter 2023. The decrease in net loss for the fourth quarter 2023 compared to the fourth quarter 2022 was due to a $229 million impairment charge in the prior year period. Excluding the impacts from impairments, net loss for the fourth quarter 2023 was primarily driven by the increase in provision for income taxes as the Company increased income from operations versus the fourth quarter 2022.

Adjusted EBITDA2 for the fourth quarter 2023 was $73 million or 31% of revenue.

Net cash provided by operating activities for the fourth quarter 2023 was $32 million, up from $29 million for the fourth quarter 2022.

Capital expenditures for the fourth quarter 2023 were $10 million, up from $9 million for the fourth quarter 2022.

Free cash flow1 for the fourth quarter 2023 was $23 million, up from $20 million for the fourth quarter 2022.

Full Year 2023 Financial Overview
Revenue for full year 2023 was $938 million, up 7% from $879 million for full year 2022. The increase in revenue for full year 2023 compared to full year 2022 was driven by a full year's adult use contribution from New Jersey in addition to adult use launches in Connecticut and Maryland.

Gross profit for full year 2023 was $475 million or 51% of revenue, up from $423 million or 48% of revenue for full year 2022. The increase in gross profit for full year 2023 compared to full year 2022 was driven primarily by increased vertical mix and revenue growth.

SG&A expense for full year 2023 was $332 million or 35% of revenue, down from $357 million or 41% of revenue for full year 2022. The decrease in SG&A expense was driven primarily by a decrease in stock based compensation.
2



Net loss for full year 2023 was $(117) million, or (13)% of revenue, down from $(269) million for full year 2022. The decrease in net loss for full year 2023 compared to the full year 2022 was due to a $229 million impairment charge in the prior year period. Excluding the impacts from impairments, net loss for the full year 2023 was primarily driven by the increase in provision for income taxes as the Company increased income from operations versus the full year 2022.
3



Adjusted EBITDA2 for full year 2023 was $305 million or 32% of revenue.

Net cash provided by operating activities for full year 2023 was $110 million, up from $94 million for full year 2022.

Capital expenditures for full year 2023 were $36 million, down from $119 million for full year 2022.

Free cash flow1 for full year 2023 was $73 million, up from $(25) million for full year 2022.

2024 Guidance
The Company issued first quarter 2024 revenue guidance of a 5-7% decline versus the prior year period as the growing dispensary count in New Jersey continues to normalize.

Fourth Quarter 2023 Operational Highlights
Expanded the Company's retail footprint across key markets by opening the following new dispensaries:
MÜV locations in Apopka, Satellite Beach and North Miami-Biscayne, Florida;
and Zen Leaf Newington, a social equity joint venture dispensary, raising the Company's Connecticut retail footprint to four locations statewide.
Commenced trading on Cboe Canada, elevating the Company's capital markets strategy and presence on a senior exchange with a global platform that spans 26 markets.
Introduced Savvy Threads, a non-plant-touching e-commerce extension of the Company's Savvy brand featuring limited-edition, artist-driven streetwear available for sale and delivery to all 50 states.
Announced the Company's participation in a coalition of industry stakeholders as a plaintiff challenging the legality of the federal government's intervention in legal intrastate cannabis commerce under the Commerce Clause and Controlled Substances Act.
Launched reimagined (the) Essence brand combining bespoke graphic art and terpene-rich full-spectrum products, including the new (the) Essence Nectar line, across core markets.

Subsequent Operational Highlights
Expanded the Company's retail footprint across key markets by opening the following new dispensaries:
MÜV Yulee in Northeast Florida, raising the Company's current statewide retail footprint to 74 dispensaries;
and in Pennsylvania, opened the Company's largest nationwide dispensary, Zen Leaf Abington, and Zen Leaf Norristown - both situated in prime Philadelphia area locations - elevating Verano's statewide footprint to 18 affiliated dispensaries.
Current operations span 13 states, comprised of 138 dispensaries and 14 production facilities with more than one million square feet of cultivation capacity.

Balance Sheet and Liquidity
As of December 31, 2023, the Company’s current assets were $394 million, including cash and cash equivalents of $175 million. The Company had a working capital deficit of $(18) million and total debt, net of issuance costs, of $446 million.

The Company’s total Class A subordinate voting shares outstanding was 344,074,096 as of December 31, 2023.
4



Conference Call and Webcast
A conference call and webcast discussing the results and answering analyst questions was recorded on February 29, 2024 at 8:30 a.m. ET / 7:30 a.m. CT.

The recorded webcast can be accessed via the following link: https://events.q4inc.com/attendee/601934273 or on the Events and Presentations page of the Company’s investor relations website at investors.verano.com.
_________________________
1 Free cash flow is a non-U.S. GAAP financial measure. It is derived from U.S. GAAP net cash provided by operating activities, which is also its most directly comparable U.S. GAAP financial measure, and is defined in this news release in the section below titled “Non-U.S. GAAP Financial Measures.” The reconciliation of free cash flow to U.S. GAAP net cash provided by operating activities is set forth below in the tables included in this news release.
2 Adjusted EBITDA is a non-U.S. GAAP financial measure. It is derived from EBITDA, another non-U.S. GAAP financial measure, and is defined in this news release in the section below titled “Non-U.S. GAAP Financial Measures.” The most directly comparable U.S. GAAP financial measure to adjusted EBITDA is net income (loss). The reconciliation of adjusted EBITDA to U.S. GAAP net income (loss) is set forth below in the tables included in this news release.


Non-U.S. GAAP Financial Measures
Verano uses non-U.S. GAAP financial information to evaluate the performance of the Company. The terms “EBIT,” “EBITDA,” “adjusted EBITDA,” and “free cash flow” do not have any standardized meaning prescribed within U.S. GAAP and therefore may not be comparable to similar measures presented by other companies. Accordingly, this non-U.S. GAAP financial information is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with U.S. GAAP.

The Company calculates EBIT as net income (loss) before interest expense and income tax expense; EBITDA as net income (loss) before interest expense, income tax expense, depreciation, and amortization; adjusted EBITDA as net income (loss) plus net interest expense, income tax expense, depreciation and amortization and also excludes certain one-time extraordinary items; and free cash flow as net cash provided by operating activities less capital expenditures. The calculations of the non-U.S. GAAP financial measures used in this news release and the reconciliations to the most comparable U.S. GAAP financial numbers are included in the tables below.

Management believes that this non-U.S. GAAP financial information is useful as a supplement to comparable U.S. GAAP financial information because it provides consistency and comparability with past financial performance and assists in comparisons with other companies, some of which use similar non-GAAP information to supplement their GAAP results. Management reviews these non-U.S. GAAP financial measures on a regular basis and uses them, together with financial measures included in the Company’s financial statements, to evaluate and manage the performance of the Company’s operations. These measures should be evaluated only in conjunction with the comparable U.S. GAAP financial numbers reported by the Company.

About Verano
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano offers a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf and MÜV dispensary banners and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano, MÜV, Savvy, BITS, Encore, and Avexia. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1,000,000 square feet of cultivation capacity. Learn more at www.verano.com.
5



Contacts:
Investors
Verano
Julianna Paterra, CFA
VP, Investor Relations
julianna.paterra@verano.com

Media
Verano
Steve Mazeika
VP, Communications
steve.mazeika@verano.com
312-348-4430

Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2023 filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.


Financial Information Tables
The following tables include select financial results and the reconciliations of the non-U.S. GAAP financial measures to the respective most directly comparable U.S. GAAP financial measures for the presented periods.
6


VERANO HOLDINGS CORP.
Highlights from Consolidated Statements of Operations
($ in Thousands)
For the Three Months Ended,For the Year Ended,
December 31, 2023September 30, 2023December 31, 2022December 31, 2023December 31, 2022
(Unaudited)(Unaudited)(Unaudited)(Audited)(Audited)
Revenues, net of Discounts$237,189 $240,088 $225,927 $938,452 $879,412 
Cost of Goods Sold, net119,579 106,868 122,591 463,246 456,350 
Gross Profit117,610 133,220 103,336 475,206 423,062 
Gross Profit %50 %55 %46 %51 %48 %
Operating Expenses
Selling, General and Administrative85,709 86,316 81,038 331,928 356,569 
Loss on Impairment of Investment in Associates— 6,571 — 6,571 — 
Loss on Impairment of Intangibles – Goodwill37,931 — 113,031 37,931 113,031 
Loss on Impairment of Intangibles – License & Fixed Assets13,686 — 116,151 13,686 116,151 
Total Operating Expenses137,326 92,887 310,220 390,116 585,751 
Income (Loss) from Investments in Associates— (45)(93)(306)1,558 
Income (Loss) from Operations(19,716)40,288 (206,977)84,784 (161,131)
Other Income (Expense), net:
Loss on Disposal of Property, Plant and Equipment(568)(234)(408)(1,123)(157)
Gain on Deconsolidation— — — — 9,560 
Gain on Previously Held Equity Interest— — — — 14,103 
Loss on Debt Extinguishment— — (7,987)(663)(7,987)
Interest Expense, net(14,708)(15,166)(15,349)(59,793)(49,431)
Other Income, net2,056 2,145 14,083 4,593 31,640 
Total Other Income (Expense), Net(13,220)(13,255)(9,661)(56,986)(2,272)
Income (Loss) Before Provision for Income Taxes and Non-Controlling Interest(32,936)27,033 (216,638)27,798 (163,403)
Provision for Income Tax (Expense) Benefit(44,350)(44,797)528 (145,146)(105,470)
Net Income (Loss) Attributable To Non-Controlling Interest(78)78 — — 291 
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries(77,208)(17,842)(216,110)(117,348)(269,164)
7


VERANO HOLDINGS CORP.
Highlights from Consolidated Balance Sheets
($ in Thousands)
December 31,December 31,
20232022
Cash and Cash Equivalents$174,760 $84,851 
Other Current Assets219,436 233,424 
Property, Plant and Equipment, net501,304 525,905 
Intangible Assets, Net1,086,146 1,180,766 
Goodwill231,291 269,088 
Other Long-Term Assets105,808 102,021 
Total Assets$2,318,745 $2,396,055 

Total Current Liabilities$412,188 $386,645 
Total Long-Term Liabilities666,477 667,860 
Total Shareholders' Equity1,240,080 1,341,550 
Non-Controlling Interest— — 
Total Liabilities and Shareholders' Equity$2,318,745 $2,396,055 
8


VERANO HOLDINGS CORP.
Segmented Revenue By State (Unaudited)


For the Three Months Ended,For the Year Ended,
Net Retail Sales by StateDecember 31, 2023December 31, 2023
($ in thousands)
Florida$59,695 $221,957 
Illinois29,299 123,040 
New Jersey26,337 126,876 
Arizona15,626 67,061 
Pennsylvania12,587 55,010 
Maryland10,875 28,594 
Connecticut8,862 29,673 
Nevada7,097 29,158 
Ohio5,868 25,152 
Massachusetts2,984 12,628 
West Virginia1,625 5,777 
Other4,264 16,500 
Total Net Retail Sales$185,119 $741,426 

For the Three Months Ended,For the Year Ended,
Wholesale Sales by StateDecember 31, 2023December 31, 2023
Gross
Net1
Gross
Net1
($ in thousands)
New Jersey$24,049 $15,511 $99,928 $51,291 
Illinois19,227 11,027 79,204 45,858 
Connecticut14,204 10,342 54,584 42,011 
Maryland8,444 5,384 28,273 19,357 
Pennsylvania7,476 3,781 29,168 15,903 
Arizona7,084 2,575 25,989 9,888 
Nevada2,924 845 10,359 2,963 
Ohio1,857 914 7,816 3,693 
Massachusetts1,640 809 6,967 3,249 
West Virginia1,665 882 5,528 2,793 
Other— — 20 20 
Total Wholesale Sales$88,570 $52,070 $347,836 $197,026 
1Net of intercompany eliminations
9


VERANO HOLDINGS CORP.
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow (Non-U.S. GAAP, Unaudited)

For the Three Months Ended,For the Year Ended,
December 31, 2023December 31, 2022December 31, 2023December 31, 2022
($ in thousands)
Net Cash Provided by Operating Activities$32,349 $29,036 $109,710 $94,347 
Purchase of property, plant, and equipment(9,827)(9,454)(36,330)(119,174)
Free Cash Flow$22,522 $19,582 $73,380 $(24,827)





VERANO HOLDINGS CORP.
Reconciliation of Net Loss to EBITDA (Non-U.S. GAAP, Unaudited)
For the Three Months Ended,For the Year Ended,
December 31, 2023September 30, 2023December 31, 2022December 31, 2023December 31, 2022
($ in thousands)
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries$(77,208)$(17,842)$(216,110)$(117,348)$(269,164)
Interest Expense, net14,708 15,166 15,349 59,793 49,431 
Income Tax Expense (Benefit)44,350 44,797 (528)145,146 105,470 
Depreciation and Amortization - COGS18,417 18,384 18,580 73,851 78,120 
Depreciation and Amortization - SG&A17,157 16,882 16,578 67,282 63,267 
Earnings (Loss) Before Interest, Taxes, Depreciation and Amortization (EBITDA)$17,424 $77,387 $(166,131)$228,724 $27,124 

10


VERANO HOLDINGS CORP.
Reconciliation of Net Loss to EBIT (Non-U.S. GAAP) and Adjusted EBITDA (Non-U.S. GAAP, Unaudited)
For the Three Months Ended,For the Year Ended,
December 31, 2023September 30, 2023December 31, 2022December 31, 2023December 31, 2022
($ in thousands)
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries$(77,208)$(17,842)$(216,110)$(117,348)$(269,164)
Interest Expense, Net14,708 15,166 15,349 59,793 49,431 
Income Tax Expense44,350 44,797 (528)145,146 105,470 
Earnings Before Interest, Taxes (EBIT)$(18,150)$42,121 $(201,289)$87,591 $(114,263)
COGS Add-backs:
Depreciation and Amortization - COGS18,417 18,384 18,580 73,851 78,120 
Acquisition, Transaction and Other Non-operating Costs— — 695 — 20,804 
Employee Stock Compensation970 625 2,231 2,669 8,003 
SG&A Add-backs:
Depreciation and Amortization - SG&A17,157 16,882 16,578 67,282 63,267 
Acquisition, Transaction and Other Non-operating Costs595 617 1,043 2,177 22,224 
Employee Stock Compensation3,281 4,062 2,599 10,561 31,051 
Impairment - Goodwill, License & Fixed Assets51,617 — 229,182 51,617 229,182 
Acquisition Adjustments and Other Income (Expense), net(511)6,658 9,094 9,123 (14,821)
Adjusted EBITDA$73,376 $89,349 $78,713 $304,871 $323,567 
Net Loss Margin(33)%(7)%(96)%(13)%(31)%
Adjusted EBITDA Margin31 %37 %35 %32 %37 %
11